[Clinical evaluation of cepharanthin for chronic idiopathic thrombocytopenic purpura].

MLA

Nakayama, S., et al. “[Clinical Evaluation of Cepharanthin for Chronic Idiopathic Thrombocytopenic Purpura].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, vol. 33, no. 3, Mar. 1992, pp. 408–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1578649&authtype=sso&custid=ns315887.

APA

Nakayama, S., Matsushita, A., Ichiba, S., & Nagai, K. (1992). [Clinical evaluation of cepharanthin for chronic idiopathic thrombocytopenic purpura]. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 33(3), 408–409.

Chicago

Nakayama, S, A Matsushita, S Ichiba, and K Nagai. 1992. “[Clinical Evaluation of Cepharanthin for Chronic Idiopathic Thrombocytopenic Purpura].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 33 (3): 408–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1578649&authtype=sso&custid=ns315887.